Last reviewed · How we verify
NCT03790215
Dydrogesterone in the Treatment of Endometrial Polyps
Phase 4 trial testing Dydrogesterone in Endometrial Polyp in 60 participants. Completed in 31 December 2019.
30 September 2019
Quick facts
| Lead sponsor | Peking Union Medical College Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 February 2019 |
| Primary completion | 30 September 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- Dydrogesterone (DYDROGESTERONE) — full drug profile →
Conditions studied
- Endometrial Polyp — all drugs for Endometrial Polyp →
Sponsor
Peking Union Medical College Hospital
Who can join
Adults 20 to 50, female only, with Endometrial Polyp. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is intended to observe the therapeutic effect of dydrogesterone on endometrial polyps and provide a reference for clinical treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03790215
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dydrogesterone
Trials testing the same drug.
- NCT05972902 — Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes · Phase 3 · unknown
- NCT05767086 — Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles · NA · completed
- NCT04788108 — Oral Progesterone for Prevention of Miscarriage in Threatened Abortion · Phase 4 · completed
- NCT03859921 — Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET · Phase 3 · recruiting
- NCT03935152 — Oral Dydrogesterone in the Management of Preterm Labor · Phase 4 · completed
Other recruiting trials for Endometrial Polyp
Currently open trials in the same condition.
- NCT06526962 — 5Fr Bipolar Electrode vs. Conical Optical 5Fr Fibers for Dual Wave-length Diode Laser for Hysteroscopic Polypectomy · recruiting
Other Peking Union Medical College Hospital trials
Trials by the same sponsor.
- NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
- NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
- NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
- NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
- NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03790215 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
- Last refreshed: 22 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03790215.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing